StockpollyBeta
Get App
Popularity #5,034
INCR · NASDAQ · Drug Manufacturers - Specialty & Generic

InterCure (INCR)

Produces and distributes pharmaceutical-grade medical cannabis through an integrated Israeli platform.

$5.42
vs last close+0.17 (+3.34%)

In millions of USD, except per-share figures · converted from ILS at the latest rate

In millionsQ1 FY23Mar 2023Q2 FY23Jun 2023Q3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025
Revenue353424242121191922222323
Cost of revenue242318181414191915152323
Gross profit11116677007700
9919155513136666
Research & development000000000000
99888811117799
Selling & marketing554455444444
General & administrative443333663355
Other expenses1077−3−322−1−1−4−4
Operating income22−9−922−13−1311−5−5
−1−2−8−2−1−1−2−2−1−1−1−1
Interest income103−200000000
Interest expense220011111122
Other non-operating income−100−700330077
Income before tax10−11−1100−15−1500−7−7
Income tax expense1−11100−3−300−1−1
Net income from continuing operations01−11−1100−12−1200−6−6
Net income02−11−1100−11−1100−6−6
EPS, basic$0.00$0.04−$0.25−$1.24$0.02$0.02−$1.31−$1.31−$0.02−$0.02−$0.56−$0.56
EPS, diluted$0.00$0.04−$0.25−$1.24$0.02$0.02−$1.31−$1.31−$0.02−$0.02−$0.56−$0.56
Weighted average shares, basic434345910109911111010
Weighted average shares, diluted434345910109911111010
EBITDA43−2−222−16−1522−12−12
Depreciation & amortization111111111111
EBIT22−2−222−16−1611−12−12